Insider · CIK 0001332669

Maslan Andrew Scott

Reports to the SEC for 1 company · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001332669

Forms 4 and 5

Insider transactions

31 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2012-08-07	AURXNuo Therapeutics, Inc.X Exercise of In-Money	Chief Financial Officer	XExercise of In-Money	+10K sh	$1.00	+$10K	112,780
2012-08-07	AURXNuo Therapeutics, Inc. · WarrantX Exercise of In-Money	Chief Financial Officer	XExercise of In-Money	−10K sh	—	—	462,643
2012-07-03	AURXNuo Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$1.08	+$5,400	102,780
2012-02-13	AURXNuo Therapeutics, Inc.X Exercise of In-Money	Chief Financial Officer	XExercise of In-Money	+8,961 sh	$0.54	+$4,810.265	97,780
2012-02-13	AURXNuo Therapeutics, Inc. · WarrantX Exercise of In-Money	Chief Financial Officer	XExercise of In-Money	−8,961 sh	—	—	477,321
2012-02-08	AURXNuo Therapeutics, Inc.C Conversion	Chief Financial Officer	CConversion	+17.9K sh	—	—	87,819
2012-02-08	AURXNuo Therapeutics, Inc.J Other	Chief Financial Officer	JOther	+1,000 sh	—	—	88,819
2012-01-17	AURXNuo Therapeutics, Inc.J Other	Chief Financial Officer	JOther	+232 sh	—	—	69,897
2011-12-01	AURXNuo Therapeutics, Inc. · Options to Purchase Shares of Common StockA Award	Chief Financial Officer	AAward	+50K sh	—	—	486,282
2011-10-17	AURXNuo Therapeutics, Inc.J Other	Chief Financial Officer	JOther	+475 sh	—	—	69,665
2011-07-15	AURXNuo Therapeutics, Inc.J Other	Chief Financial Officer	JOther	+625 sh	—	—	69,190
2011-05-23	AURXNuo Therapeutics, Inc. · Options to Purchase Shares of Common StockA Award	Chief Financial Officer	AAward	+10K sh	—	—	436,282
2011-04-15	AURXNuo Therapeutics, Inc.J Other	Chief Financial Officer	JOther	+625 sh	—	—	68,565
2011-03-31	AURXNuo Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$0.36	+$3,600	67,940
2011-01-18	AURXNuo Therapeutics, Inc.J Other	Chief Financial Officer	JOther	+420 sh	—	—	57,940
2010-10-15	AURXNuo Therapeutics, Inc.J Other	Chief Financial Officer	JOther	+540 sh	—	—	57,520
2010-07-15	AURXNuo Therapeutics, Inc.J Other	Chief Financial Officer	JOther	+480 sh	—	—	56,980
2010-07-13	AURXNuo Therapeutics, Inc. · Options to purchase shares of common stockA Award	Chief Financial Officer	AAward	+50K sh	—	—	426,282
2010-04-09	AURXNuo Therapeutics, Inc. · 10% Series D Convertible StockP Purchase	Chief Financial Officer	PPurchase	0 sh	—	—	367,321
2010-04-09	AURXNuo Therapeutics, Inc. · Common Stock WarrantsP Purchase	Chief Financial Officer	PPurchase	0 sh	—	—	376,282
2009-09-17	AURXNuo Therapeutics, Inc. · Option to purchase common stockA Award	Chief Financial Officer	AAward	+30K sh	—	—	349,400
2009-08-14	AURXNuo Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+8,800 sh	$0.57	+$5,016	56,500
2009-08-14	AURXNuo Therapeutics, Inc. · WARRANTSP Purchase	Chief Financial Officer	PPurchase	+4,400 sh	—	—	319,400
2009-05-22	AURXNuo Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+2,500 sh	$0.52	+$1,300	47,700
2009-05-13	AURXNuo Therapeutics, Inc. · Options to purchase Common StockA Award	Chief Financial Officer	AAward	+35K sh	—	—	315,000
2009-01-02	AURXNuo Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+900 sh	$0.25	+$225	40,900
2009-01-02	AURXNuo Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+4,300 sh	$0.27	+$1,161	45,200
2006-10-11	AURXNuo Therapeutics, Inc. · Option to Purchase Common StockA Award	Chief Financial Officer	AAward	+50K sh	—	—	150,000
2006-03-17	AURXNuo Therapeutics, Inc. · Options to Purchase Common StockA Award	Chief Financial Officer	AAward	+40K sh	—	—	100,000
2006-03-17	AURXNuo Therapeutics, Inc. · Option to Purchase Common StockA Award	Chief Financial Officer	AAward	+40K sh	—	—	100,000
2006-01-12	AURXNuo Therapeutics, Inc. · Option to Purchase Common StockA Award	Chief Financial Officer	AAward	+60K sh	—	—	60,000

Recent filings

Accepted (ET)
Aug 84
Maslan Andrew Scott0001144204-12-043690
SEC(opens sec.gov)
Jul 34
Maslan Andrew Scott0001144204-12-037941
SEC(opens sec.gov)
Feb 144
Maslan Andrew Scott0001144204-12-008078
SEC(opens sec.gov)
Feb 104
Maslan Andrew Scott0001144204-12-007338
SEC(opens sec.gov)
Jan 304
Maslan Andrew Scott0001144204-12-004568
SEC(opens sec.gov)
Dec 54
Maslan Andrew Scott0001144204-11-068248
SEC(opens sec.gov)
Oct 174
Maslan Andrew Scott0001144204-11-058003
SEC(opens sec.gov)
Jul 184
Maslan Andrew Scott0001144204-11-040981
SEC(opens sec.gov)
May 254
Maslan Andrew Scott0001144204-11-032414
SEC(opens sec.gov)
Apr 194
Maslan Andrew Scott0001144204-11-022881
SEC(opens sec.gov)
Mar 314
Maslan Andrew Scott0001144204-11-019001
SEC(opens sec.gov)
Jan 264
Maslan Andrew Scott0001144204-11-004120
SEC(opens sec.gov)
Oct 214
Maslan Andrew Scott0001144204-10-054863
SEC(opens sec.gov)
Jul 194
Maslan Andrew Scott0001144204-10-038358
SEC(opens sec.gov)
Jul 154
Maslan Andrew Scott0001144204-10-037981
SEC(opens sec.gov)
Apr 134
Maslan Andrew Scott0001144204-10-019757
SEC(opens sec.gov)

Companies

Nuo Therapeutics, Inc.Chief Financial OfficerAURX

Address

416 HUNGERFORD DRIVE SUITE 330

ROCKVILLE, MD, 20850